Understanding haemorrhagic risk following thrombolytic therapy in patients with intermediate-risk and high-risk pulmonary embolism: a hypothesis paper

While systemic intravenous thrombolysis decreases mortality in patients with high-risk pulmonary embolism (PE), it clearly increases haemorrhagic risk. There are many contraindications to thrombolysis, and efforts should aim at selecting those patients who will benefit most, without suffering compli...

Descripción completa

Detalles Bibliográficos
Autores principales: Abraham, Paul, Arroyo, Diego A, Giraud, Raphael, Bounameaux, Henri, Bendjelid, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Pulmonary Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845427/
https://www.ncbi.nlm.nih.gov/pubmed/29531763
http://dx.doi.org/10.1136/openhrt-2017-000735

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845427/
https://www.ncbi.nlm.nih.gov/pubmed/29531763
http://dx.doi.org/10.1136/openhrt-2017-000735

Ejemplares similares